Department of Health and Human Services June 14, 2016 – Federal Register Recent Federal Regulation Documents

Arthritis Advisory Committee; Notice of Meeting
Document Number: 2016-14017
Type: Notice
Date: 2016-06-14
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Arthritis Advisory Committee. The general function of the committee is to provide advice and recommendations to the Agency on FDA's regulatory issues. The meeting will be open to the public.
Proposed Data Collection Submitted for Public Comment and Recommendations
Document Number: 2016-14016
Type: Notice
Date: 2016-06-14
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
The Centers for Disease Control and Prevention (CDC), as part of its continuing efforts to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies to take this opportunity to comment on proposed and/or continuing information collections, as required by the Paperwork Reduction Act of 1995. This notice invites comment on the Presidential Youth Fitness Program (PYFP) Evaluation. The Evaluation will be conducted in approximately 11 middle schools implementing the PYFP and 11 match comparison schools and will focus on both process and outcome measures.
Health IT Policy Committee Advisory Meeting; Notice of Meeting
Document Number: 2016-13998
Type: Notice
Date: 2016-06-14
Agency: Department of Health and Human Services
Health IT Standards Committee Advisory Meeting; Notice of Meeting
Document Number: 2016-13997
Type: Notice
Date: 2016-06-14
Agency: Department of Health and Human Services
Advisory Councils or Committees; Delegation of Authority
Document Number: 2016-13995
Type: Notice
Date: 2016-06-14
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Osteoporosis: Nonclinical Evaluation of Drugs Intended for Treatment; Draft Guidance for Industry; Availability
Document Number: 2016-13988
Type: Notice
Date: 2016-06-14
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled ``Osteoporosis: Nonclinical Evaluation of Drugs Intended for Treatment.'' This draft guidance provides recommendations to industry for designing a nonclinical development program to support approval of drugs to treat osteoporosis. This guidance also discusses the nonclinical development of biopharmaceuticals (e.g., recombinant proteins and monoclonal antibodies).
Proposed Data Collection Submitted for Public Comment and Recommendations
Document Number: 2016-13982
Type: Notice
Date: 2016-06-14
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies to take this opportunity to comment on proposed and/or continuing information collections, as required by the Paperwork Reduction Act of 1995. This notice invites comment on the CDC I- Catalyst program. The I-Catalyst program is intended to help CDC employees get their ideas out of the starting blocks and down the track through a discovery, ideation, and prototyping process. The expected result is that CDC staff will be empowered to implement innovative strategies and solutions that create value for a set of beneficiaries.
National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings
Document Number: 2016-13931
Type: Notice
Date: 2016-06-14
Agency: Department of Health and Human Services, National Institutes of Health
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.